| Date Filed | Type | Description |
| 10/06/2023 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Granted 6,925 shares
@ $0 |
|
| 07/06/2023 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Granted 4,152 shares
@ $0 |
|
| 06/09/2023 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Granted 65,000 options to buy
@ $6.7, valued at
$435.5k
|
|
| 04/06/2023 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Granted 7,716 shares
@ $0 |
|
| 03/20/2023 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on AGILENT TECHNOLOGIES, INC.|
Txns:
| Granted 1,658 shares
@ $136.82, valued at
$226.8k
Granted 741 shares
@ $136.82, valued at
$101.4k
|
|
| 01/06/2023 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Granted 6,702 shares
@ $0 |
|
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2022 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on Lyell Immunopharma, Inc.|
Txns:
| Exercised 145,380 options to buy
@ $0.1, valued at
$14.5k
|
|
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2022 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Granted 2,880 shares
@ $0 |
|
| 03/21/2022 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on AGILENT TECHNOLOGIES, INC.|
Txns:
| Granted 1,785 shares
@ $136.82, valued at
$244.2k
Granted 797 shares
@ $136.82, valued at
$109k
|
|
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/10/2021 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Converted 2,031,250 shares
@ $0
Converted 1,075,000 convertible preferred
@ $0
Converted 800,000 convertible preferred
@ $0
Converted 156,250 convertible preferred
@ $0 |
|
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2020 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on AGILENT TECHNOLOGIES, INC.|
Txns:
| Granted 3,081 shares
@ $73.009, valued at
$224.9k
Granted 1,027 shares
@ $73.009, valued at
$75k
|
|
| 11/22/2019 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Disposed/sold 23,088 shares
@ $0
Disposed/sold 10,000 options to buy
@ $91.01, valued at
$910.1k
Disposed/sold 13,266 options to buy
@ $77.38, valued at
$1M
Disposed/sold 1,454 restricted stock units
@ $0
Disposed/sold 4,756 restricted stock units
@ $0 |
|
| 06/05/2019 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Granted 4,756 restricted stock units
@ $0 |
|
| 03/22/2019 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on AGILENT TECHNOLOGIES INC|
Txns:
| Granted 2,823 shares
@ $82, valued at
$231.5k
Granted 627 shares
@ $82, valued at
$51.4k
|
|
| 06/15/2018 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Granted 13,266 options to buy
@ $77.38, valued at
$1M
Granted 1,454 restricted stock units
@ $0 |
|
| 04/19/2018 |
3
| Bishop Hans Edgar (Director) has filed a Form 3 on CELGENE CORP /DE/ |
| 03/23/2018 |
4
| Bishop Hans Edgar (Director) has filed a Form 4 on AGILENT TECHNOLOGIES INC|
Txns:
| Granted 2,876 shares
@ $67.47, valued at
$194k
Granted 1,438 shares
@ $67.47, valued at
$97k
|
|
| 03/07/2018 |
4
| Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Unknown transaction of 2,263,948 shares
@ $87, valued at
$197M
Disposed/sold 48,829 shares
@ $87, valued at
$4.2M
Disposed/sold 33,133 shares
@ $0
Disposed/sold 66,426 shares
@ $0
Disposed/sold 35,893 shares
@ $0
Disposed/sold 451,756 options to buy
@ $6.36, valued at
$2.9M
Disposed/sold 140,000 options to buy
@ $48.06, valued at
$6.7M
Disposed/sold 200,000 options to buy
@ $24.5, valued at
$4.9M
Disposed/sold 205,823 options to buy
@ $20.76, valued at
$4.3M
|
|
| 02/09/2018 |
4
| Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,346 shares
@ $85.49, valued at
$371.5k
Gifted 116,280 shares
@ $0 |
|
| 02/02/2018 |
4
| Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 66,426 shares
@ $0 |
|
| 01/18/2018 |
4
| Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Sold 65,820 shares
@ $44.7163, valued at
$2.9M
Sold 89,888 shares
@ $45.5321, valued at
$4.1M
Sold 49,082 shares
@ $46.5247, valued at
$2.3M
Sold 23,003 shares
@ $47.6925, valued at
$1.1M
Sold 42,457 shares
@ $48.5648, valued at
$2.1M
Exercised 245,750 options to buy
@ $6.36, valued at
$1.6M
|
|
| 10/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|